The Use of Molecular Studies for Diagnosis of Undifferentiated Tumors (FREE)

Absent other diagnostic tools, BRAF/NRAS/KIT genotyping appears to provide viable surrogate markers for diagnosis of malignant melanoma in undifferentiated tumors.